Stocks and Investing Stocks and Investing
Thu, March 2, 2017

Christopher Marai Initiated (SRPT) at Strong Buy on, Mar 2nd, 2017


Published on 2024-10-25 20:23:37 - WOPRAI, Christopher Marai
  Print publication without navigation


Christopher Marai of Nomura, Initiated "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy on, Mar 2nd, 2017.

Christopher has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, 0 agree with Christopher's Rating of Hold.



This is the rating of the analyst that currently disagrees with Christopher


  • Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $40 on, Thursday, December 22nd, 2016

Contributing Sources